Willy A Flegel Selected Research

Willy A Flegel Research Topics

Disease

6	Myositis (Idiopathic Inflammatory Myopathies) 12/2023 - 01/2022
6	Dermatomyositis (Dermatopolymyositis) 12/2023 - 01/2022
4	Hemolysis 01/2021 - 01/2011
4	Sickle Cell Anemia (Hemoglobin S Disease) 07/2020 - 10/2010
3	Transfusion Reaction 04/2024 - 07/2015
3	COVID-19 04/2024 - 08/2021
2	Hypersensitivity (Allergy) 04/2024 - 05/2014
2	Neoplasms (Cancer) 12/2023 - 01/2023
2	Ulcer 11/2023 - 01/2022
2	Exanthema (Rash) 11/2023 - 01/2023
2	Anosmia 11/2016 - 03/2015
2	Transfusion-Related Acute Lung Injury 03/2016 - 05/2012
1	Tick Bites 04/2024
1	Immediate Hypersensitivity 04/2024
1	Edema (Dropsy) 11/2023
1	Polymyositis 02/2023
1	Inclusion Body Myositis 02/2023
1	Autoimmune Diseases (Autoimmune Disease) 02/2023
1	Fatigue 02/2023
1	Sudden Infant Death (SID) 11/2022
1	monosomy Chromosome 7 12/2021
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021
1	Cicatrix (Scar) 01/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2021
1	Malaria 10/2020
1	Disease Susceptibility (Diathesis) 10/2020
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Atherosclerosis 01/2018
1	Neutropenia 01/2018
1	Disease Progression 11/2017
1	Ageusia (Hypogeusia) 11/2016
1	Inborn Genetic Diseases (Disease, Hereditary) 06/2011
1	Gastroenteritis 06/2011
1	Stroke (Strokes) 10/2010
1	Ovarian Hyperstimulation Syndrome 08/2008
1	Infertility (Sterility) 08/2008
1	Hemolytic Anemia 06/2005

Drug/Important Bio-Agent (IBA)

7	AntibodiesIBA 02/2022 - 01/2011
6	AntigensIBA 04/2024 - 03/2015
6	AutoantibodiesIBA 12/2023 - 01/2022
5	Blood Group Antigens (Blood Groups)IBA 11/2022 - 08/2008
4	IsoantibodiesIBA 01/2021 - 05/2012
3	HLA-DRB1 Chains (HLA DRB1)IBA 12/2023 - 01/2021
2	Complement System Proteins (Complement)IBA 02/2023 - 07/2015
2	EnzymesIBA 01/2023 - 02/2022
2	ImmunosorbentsIBA 01/2023 - 02/2022
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2021
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021 - 07/2015
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020 - 05/2014
1	SteroidsIBA 04/2024
1	OligosaccharidesIBA 04/2024
1	Immunoglobulin E (IgE)IBA 04/2024
1	Histamine Antagonists (Antihistamines)IBA 04/2024
1	HLA-DQA1 antigen (HLA DQA1)IBA 12/2023
1	Complement C4 (Complement Component 4)IBA 02/2023
1	HLA-DR3 Antigen (HLA DR3 Antigen)IBA 02/2023
1	SS-A antibodiesIBA 01/2023
1	HLA-B Antigens (HLA-B)IBA 12/2021
1	HLA-A Antigens (HLA-A)IBA 12/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021
1	Sirolimus (Rapamycin)FDA Link 01/2021
1	Glycoproteins (Glycoprotein)IBA 10/2020
1	Complement C5 (Complement 5)IBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	eculizumab FDA Link 01/2020
1	Scianna antibodyIBA 06/2019
1	CytokinesIBA 01/2018
1	Genetic Markers (Genetic Marker)IBA 11/2016
1	Immunoglobulin G (IgG)IBA 07/2015
1	Immunoglobulins (Immunoglobulin)IBA 07/2015
1	Surface Antigens (Surface Antigen)IBA 03/2015
1	Allopurinol (Remid)FDA LinkGeneric 05/2014
1	abacavir (Ziagen)FDA Link 05/2014
1	Carbamazepine (Tegretol)FDA LinkGeneric 05/2014
1	Nonsense Codon (Nonsense Mutation)IBA 06/2011
1	NucleotidesIBA 10/2010

Therapy/Procedure

5	Transplantation 01/2021 - 06/2005
3	Hematopoietic Stem Cell Transplantation 07/2020 - 10/2010
1	Extracorporeal Membrane Oxygenation 04/2024
1	Self-Help Devices (Assistive Technology) 01/2022
1	Blood Transfusion (Blood Transfusions) 01/2021
1	Therapeutics 10/2020
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2020
1	Drug Therapy (Chemotherapy) 06/2011
1	Donor Selection 10/2010